These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 14663658

  • 21. The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients.
    Lee BH, Kim YK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):658-62. PubMed ID: 16466670
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA, de Jonghe-Rouleau AP, Stienstra-Liem LH.
    Ned Tijdschr Geneeskd; 2004 Sep 11; 148(37):1801-4. PubMed ID: 15495506
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets.
    Normann C, Schmauss M, Bakri N, Gerwe M, Schreiner A.
    Pharmacopsychiatry; 2006 Nov 11; 39(6):209-12. PubMed ID: 17124642
    [Abstract] [Full Text] [Related]

  • 26. Effect of risperidone on prolactinoma--a case report.
    Mendhekar DN, Jiloha RC, Srivastava PK.
    Pharmacopsychiatry; 2004 Jan 11; 37(1):41-2. PubMed ID: 14750048
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN, Jiloha RC.
    Aust N Z J Psychiatry; 2005 Oct 11; 39(10):947-8. PubMed ID: 16168023
    [No Abstract] [Full Text] [Related]

  • 31. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
    Parellada E, Andrezina R, Milanova V, Glue P, Masiak M, Turner MS, Medori R, Gaebel W.
    J Psychopharmacol; 2005 Sep 11; 19(5 Suppl):5-14. PubMed ID: 16144781
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Risperidone treatment of febrile catatonia in first-episode psychosis.
    Duggal HS.
    Gen Hosp Psychiatry; 2005 Sep 11; 27(1):80-1. PubMed ID: 15694223
    [No Abstract] [Full Text] [Related]

  • 34. Steroid-induced psychosis in an adolescent: treatment and prophylaxis with risperidone.
    Hergüner S, Bilge I, Yavuz Yilmaz A, Tüzün DU.
    Turk J Pediatr; 2006 Sep 11; 48(3):244-7. PubMed ID: 17172069
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Health resource utilization associated with switching to risperidone long-acting injection.
    Young CL, Taylor DM.
    Acta Psychiatr Scand; 2006 Jul 11; 114(1):14-20. PubMed ID: 16774656
    [Abstract] [Full Text] [Related]

  • 37. Risperidone long-acting injection: a prospective 3-year analysis of its use in clinical practice.
    Taylor DM, Fischetti C, Sparshatt A, Thomas A, Bishara D, Cornelius V.
    J Clin Psychiatry; 2009 Feb 11; 70(2):196-200. PubMed ID: 19026261
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.